Innovative Drugs Sold Under the Special Access Programme Can Receive Data Protection in Canada

May 18, 2011

Tags:

Food and Drug Regulatory Intellectual Property Intellectual Property Litigation Litigation and Dispute Resolution Patents Pharmaceuticals

Related Expertise

Related Insights

Surviving and Thriving in the Post-Legalization Cannabis Industry
Le gouvernement du Québec limite l'utilisation des programmes de fidélisation et de soutien aux patients dans un nouveau projet de règlement
Québec Government Limits use of Loyalty Cards and Patient Support in Draft Regulation
Cannabis Legalization One Step Closer With Regulations Finalized
A New Leaf for Canada: Senate Passes Draft Cannabis Act

Back